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1. Summary 
Background: Approximately 70% of the patients who receive chemotherapy suffer 
from fatigue, which lowers their quality of life and also has a negative influence on 
therapeutic efficacy. Previous studies have suggested a relationship between blood 
carnitine levels and fatigue. We conducted a prospective observational study to examine 
the relationship between carnitine pharmacokinetics and chemotherapy-induced fatigue 
in patients receiving cancer chemotherapy regimens that included cisplatin.  
Patients and Methods: Examined eleven patients were received chemotherapy 
including cisplatin administration (60–80mg/m2). We performed 24-h urine collection 
and took blood samples on day 1 (before the initiation of chemotherapy) and days 2, 3, 
4, and 8 in order to measure the carnitine concentrations of serum and urine. These were 
compared with measures of self-reported fatigue. The primary endpoint was the change 
in self-reported fatigue subscales from baseline to day 8.  
Results: Urinary carnitine concentrations differed significantly on days 2 and 3 (P = 
0.003). The Functional Assessment of Chronic Illness Therapy-Fatigue scale version 4A 
score on day 8 indicated significantly higher levels of fatigue, as compared to day 1 (P 
= 0.013). 
Conclusion: This study suggested that there was an association the urinary carnitine 
levels and self-reported fatigue. 
 
